Why Amdocs Stock Is Back in Focus After Its Latest Earnings

Amdocs (DOX) has drawn fresh attention after reporting second quarter fiscal 2026 results that topped earnings and revenue expectations, while also updating its full year guidance to reflect moderate growth and a more cautious outlook.

Even with the recent earnings beat, Amdocs’ momentum has been weak. The share price is down 14.98% over 90 days and the 1-year total shareholder return has declined 36.94%. This indicates that sentiment has cooled despite operational progress.

If this earnings update has you reassessing your tech exposure, it could be a good moment to scan for 48 AI infrastructure stocks. That screener can help you spot other infrastructure players tied to AI workloads.

With the stock down sharply over 1 and 3 years despite recent earnings and an indicated intrinsic discount, the real question is whether Amdocs is now underappreciated or if the market is already accounting for its future growth.

Most Popular Narrative: 30.6% Undervalued

Compared to the latest $56.40 close, the most followed narrative points to a fair value of $81.21, framing Amdocs as materially underpriced on modeled fundamentals.

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services. This is expanding its total addressable market and supporting sustained topline revenue growth.

Curious what earnings path, margin profile, and exit multiple need to line up for that valuation to hold? The narrative is built on specific growth rates, rising profitability, and a tighter share count that all have to work together.

Result: Fair Value of $81.21 (UNDERVALUED)

However, this hinges on telecom clients maintaining digital transformation budgets, and on Amdocs managing concentration risk with a small group of large customers.

Next Steps

With sentiment divided between recent share price weakness and an undervaluation narrative, it makes sense to check the details yourself and act promptly. To see what has investors optimistic, review the 5 key rewards

Looking for more investment ideas?

If Amdocs has sharpened your thinking, do not stop here. Broaden your watchlist with other ideas that could fit your goals and risk comfort.

• Target stability by checking stocks with resilient finances through the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for pricing gaps by reviewing companies flagged as 44 high quality undervalued stocks.
• Prioritize income by scanning payouts from 8 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.